Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.
about
Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cells.DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy.Somatostatin receptor based imaging and radionuclide therapy.Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amountReceptor-mediated tumor targeting based on peptide hormones.In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapy.α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors.Radioimmunotherapy of infection with Bi-labeled antibodiesCaspase-mediated cleavage of beta-catenin precedes drug-induced apoptosis in resistant cancer cells.Peroxisome proliferator-activated receptor gamma ligand-mediated apoptosis of hepatocellular carcinoma cells depends upon modulation of PI3Kinase pathway independent of Akt.Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments.Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases.
P2860
Q33455875-1C8D9455-07BA-4349-824B-B8D3CD3E93B7Q35091643-4BF22583-F19C-4137-A12C-858242594599Q35296661-56D38815-5C9E-4DDF-92C7-26F0434DB2D7Q35675498-A8D7DE89-C479-49E0-AD0A-F5FB62CAB63DQ37641368-5ED04615-A249-4D70-8DB2-9FF69D146569Q38696649-98F9577C-01B6-4B36-B1D4-8F8BDD71D4EAQ38715106-514FD129-562F-4780-9592-84D0AE78A733Q38909078-FCF3A569-9CD3-42A9-8E2F-B697F44FAE03Q39557992-A1A9ABD1-50CE-422A-B9A2-9365BFA9A9F6Q39872214-7D77C659-0917-4C67-9918-D7F4122E1048Q41468565-1ED5169A-B979-41D3-8171-CDB8717C2F98Q42345704-1C3163DC-16DF-42D9-9F54-8D8B06A3C96BQ47152190-A6506A9B-C658-45ED-B31F-A249E3D82B18
P2860
Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Somatostatin-receptor-targeted ...... ncreatic adenocarcinoma cells.
@en
type
label
Somatostatin-receptor-targeted ...... ncreatic adenocarcinoma cells.
@en
prefLabel
Somatostatin-receptor-targeted ...... ncreatic adenocarcinoma cells.
@en
P2093
P50
P1476
Somatostatin-receptor-targeted ...... ancreatic adenocarcinoma cells
@en
P2093
Jeffrey P Norenberg
Michael G Stabin
Tamara L Anderson
P304
P356
10.1016/J.NUCMEDBIO.2006.11.006
P577
2007-02-01T00:00:00Z